| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.7 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |